Interestingly, we found significantly higher expression levels of serum IL-6 (p = 0.011) and IL-8 (p = 0.018) in the GC patients with serum CA19-9 greater than 37U/mL (standard clinical cut-off) (Fig. 4k, l). Here, CXCL8 is linked to gastric cancer.